Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin.
about
The multifaceted mast cell in inflammatory bowel diseaseEosinophils in infection and intestinal immunityEssential role for mast cell tryptase in acute experimental colitisEndogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's diseaseTryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndromeReview article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology.Cloning and expression of human colon mast cell carboxypeptidaseMast cell function: a new vision of an old cell.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Intestinal stricture in Crohn's disease.Effect of royal jelly on experimental colitis Induced by acetic acid and alteration of mast cell distribution in the colon of rats.Identification of histamine receptors and effects of histamine on murine and simian colonic excitability.Serum laminin and collagen IV in inflammatory bowel disease.Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.Key role of mast cells and their major secretory products in inflammatory bowel disease.Modulation of visceral pain and inflammation by protease-activated receptors.Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis.Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy.Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2.Reversibility of Stricturing Crohn's Disease-Fact or Fiction?Inhibition of tryptase release from human colon mast cells by protease inhibitors.Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats.Endogenous IGF-I and alpha v beta3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis.A novel model for studying ileitis-induced visceral hypersensitivity in goats.Functional role of eosinophils in gastrointestinal inflammation.Novel insights on the role of the innate immune system in systemic sclerosis.Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?Histamine and gut mucosal immune regulation.Increased expression of protease-activated receptor-2 in mucosal mast cells in Crohn's ileitis.The role of mast cells in bacterial enteritis.Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice.Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells.The role of eosinophils in inflammatory bowel disease.Basement membrane components.Dietary supplementation with Bifidobacterium lactis NCC2818 from weaning reduces local immunoglobulin production in lymphoid-associated tissues but increases systemic antibodies in healthy neonates.Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome.Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease.
P2860
Q27026764-BA05EF39-6F87-4791-A7F5-261980EB6715Q27028076-DC6E04C9-014E-4397-A442-E3F9D10E20CEQ30497838-F777875B-BFAF-4E4C-AED2-68A47A934253Q33618488-1F83BE77-1B5D-4D5E-AC80-896791F79CA6Q33872709-0AB4F8A9-390B-4284-9148-B519F9D48398Q33874478-0452DE16-9597-4682-840D-6CE6739971A7Q34294652-5901EDC6-ACD9-47B7-A146-7EBAEA899E4CQ34430917-A3AF93D1-2FD6-4C3A-A628-51FDF1EC8878Q34504710-6D3C2415-4E8B-45A5-A7AC-EB4760A689D4Q35046178-77FCB295-29BD-4DD6-B8EF-8C7DCCC4E530Q35197290-BFC8782D-9B1B-4896-A457-54B27F09802FQ35214350-DAA10E4C-4929-4CBA-A63A-5AE358E4B411Q35587152-7B6E70AC-CCBE-4F25-8266-DD465F95A30EQ35597021-EE7F9B81-70C3-4841-BC40-DF7B12D3EACEQ35648042-1FF81258-A040-4517-A3D2-0E0CDB0D6193Q35722704-DCCDDB62-4A7D-4BE4-89AE-3B66C8D53FD9Q35872741-9ACA5B8E-6F77-43F1-AD19-79484709292FQ36016817-EE974822-46A8-40F1-A430-EAA4C3B94124Q36345926-9EADDAC5-EC7B-4DEC-92C3-23AE2BDB84D2Q36368565-20416BF8-1343-4485-8A0B-988F3EE9A33AQ36373253-A2BDE0AD-77C3-4C70-A8C8-47089AE79AFCQ36496245-8AC78EFE-4DA9-41FF-B2C6-02E42B1DEC4EQ37116356-8C751BA0-8BC2-4DC8-8653-889102BA8533Q37231304-027D3D09-AB90-4103-89BF-296799ADF748Q37315879-95E9E825-6118-4DC1-A395-6FF4437E6FD7Q37367619-220E22EF-2501-448A-A36E-840D1F41780EQ37905792-A7948B81-190B-448D-82A6-C084471A4CC9Q38014502-865DABD4-D281-41AB-BC8C-A196664781C5Q38167039-F1DDC77E-57FF-4669-8F08-D4BE70E0BEB7Q39845444-46ED4529-AF1A-4D22-AC77-222E21B6552DQ41817153-8A038CA2-734A-4352-A59A-FA1B644825D5Q42117052-8BB36320-669F-42FD-984D-C12CF2F80421Q42216388-2004D360-44E0-444D-8FC7-F8785D7E66C6Q42522030-4D98D92D-9B76-4D22-86F0-0F31AEF2F717Q43004043-1B2BA24F-7C5C-474C-8083-2B017E2C2FB5Q43010902-52C8FE19-B1B8-4891-A5B9-04ED0B807307Q44072920-1533C0E7-ECDB-4506-A8EB-5C307955A330Q44575101-71D7BDB2-694C-491D-99BD-30AA5262FA50Q44623460-983695FB-6849-4F4E-9D99-79EE1337E6C1Q54511452-D51FFDBA-EACB-4CD3-9685-1FF79E1171D0
P2860
Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@ast
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@en
type
label
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@ast
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@en
prefLabel
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@ast
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@en
P2093
P2860
P356
P1433
P1476
Strictures in Crohn's disease ...... th fibronectin or vitronectin.
@en
P2093
Gelbmann CM
Köllinger M
Mestermann S
Schölmerich J
P2860
P304
P356
10.1136/GUT.45.2.210
P407
P577
1999-08-01T00:00:00Z